In a previous study, it was demonstrated that the expression of AKT and ERK phosphorylation was inhibited after heteronemin treatment in human renal carcinoma cells, but the molecular mechanism was not further explored [31]. The gene discussed is AKT1; the disease is renal carcinoma.